Viewing Study NCT06528522



Ignite Creation Date: 2024-10-26 @ 3:36 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06528522
Status: NOT_YET_RECRUITING
Last Update Posted: None
First Post: 2024-07-12

Brief Title: Impact of Smoking on Salivary Interleukin IL-39 IL-41 IL-1β TNF-α Levels in Periodontal Disease
Sponsor: None
Organization: None

Study Overview

Official Title: Impact of Smoking on Salivary Inflammatory Cytokines Interleukin IL-39 IL-41 IL-1β TNF-α in Periodontal Disease
Status: NOT_YET_RECRUITING
Status Verified Date: 2024-07
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The goal of this observational study is to evaluate if the measurement of salivary Interleukin IL-39 IL-41 IL-1Betaβ and Tumor necrosis factor-alpha TNF-α levels can aid in the early diagnosis of periodontitis in patients with varying periodontal conditions both smokers and non-smokers The main questions it aims to answer are

Can salivary IL-39 IL-41 IL-1β and TNF-α levels be used as biomarkers for the early diagnosis of periodontitis How do IL-41 and IL-39 levels correlate with smoking status in periodontal healthy and periodontitis patients Researchers will compare the salivary biomarker levels between smokers and non-smokers to see if smoking affects these levels

Participants will

Provide salivary samples for biomarker analysis Undergo a comprehensive periodontal examination to determine their periodontal status
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None